TISSUE CONCENTRATIONS OF LEVONORGESTREL IN WOMEN USING A LEVONORGESTREL‐RELEASING IUD
This study measured levonorgestrel concentrations in uterine, fallopian tube, and fat tissues of women using IUDs or oral treatment, finding similar levels across most tissues except for higher endometrial concentrations with the IUD.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (17)
- W57960152 via openalex
- W106328369 via openalex
- W1650416388 via openalex
- W1775749144 via openalex
- W1974306598 via openalex
- W1986793572 via openalex
- W1994486622 via openalex
- W1997051909 via openalex
- W2013422533 via openalex
- W2033164135 via openalex
- W2037163508 via openalex
- W2076818052 via openalex
- W2081101461 via openalex
- W2105587557 via openalex
- W2130189546 via openalex
- W2169614806 via openalex
- W2411114100 via openalex
Cited by (40)
- High-intensity focused ultrasound combined with hysteroscopic insertion of levonorgestrel-releasing intrauterine system for intrinsic adenomyosis: a retrospective observational study 2025
- Strategies to Improve Assisted Reproductive Technique Outcomes in Women with Adenomyosis: A Narrative Review 2025
- The efficacy of the levonorgestrel intrauterine system versus oral megestrol acetate in treating atypical endometrial hyperplasia: a superior randomized controlled trial 2024
- Levonorgestrel-releasing intrauterine system versus oral progestogens for non-atypical endometrial hyperplasia: predictors for treatment failure 2023
- Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: A prospective, open-label, randomized controlled phase II study 2023
- Comparing the pharmacokinetic and pharmacodynamic qualities of current and future therapies for uterine fibroids 2022
- An Overview of the Basic Knowledge of Levonorgestrel-Releasing Intrauterine System 2021
- Effect of pretreatment with a levonorgestrel-releasing intrauterine system on IVF and vitrified–warmed embryo transfer outcomes in women with adenomyosis 2019
- Levonorgestrel-releasing intra-uterine systems as female contraceptives 2018
- HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia 2016
- Erratum: HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia 2016
- Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials 2015
- Effects of Levonorgestrel-Releasing Intrauterine System on Lymphangiogenesis of Adenomyosis 2015
- Levonorgestrel-releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasia. 2014
- Levonorgestrel-releasing intrauterine device used for dysmenorrhea: five-year literature review 2014
- LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study 2013
- LNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomized controlled trial 2013
- Effect of a hormone-releasing intrauterine system (Mirena®) on aromatase and Cox-2 expression in patients with adenomyosis submitted or not, to endometrial resection 2012
- Added health benefits of the levonorgestrel contraceptive intrauterine system and other hormonal contraceptive delivery systems 2012
- Levonorgestrel intra-uterine system as a treatment option for complex endometrial hyperplasia 2011
- Levonorgestrel‐releasing intrauterine system (Mirena <sup>®</sup> ) and Depot medroxyprogesterone acetate (Depoprovera) as long‐term maintenance therapy for patients with moderate and severe endometriosis: A randomised controlled trial 2010
- Induction of a local pseudo-pregnancy for the treatment of endometriosis 2009
- Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium 2009
- Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS 2009
- Mirena® (Levonorgestrel intrauterine system): A successful novel drug delivery option in contraception 2009
- Levonorgestrelį išskiriančios gimdos spiralės vartojimas ginekologijoje 2009
- Induction of a local pseudo-pregnancy via levonorgestrel-loaded microspheres for the treatment of endometriosis in a rabbit model 2009
- Levonorgestrel-Releasing Intrauterine System for the Treatment of Endometriosis: Biological and Clinical Evidence 2007
- Innovations in Contraception: A Review 2007
- Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging 2007
- Current diagnostic and treatment strategies for adenomyosis 2006
- Medical and surgical management of adenomyosis 2006
- Medicated intrauterine systems for treatment of endometriosis-associated pain 2006
- The role of the levonorgestrel-releasing intrauterine device in the management of symptomatic endometriosis 2005
- Insertion of Mirena after Endometrial Resection in Patients with Adenomyosis 2003
- Efficacy of the levonorgestrel intrauterine system in treating menorrhagia: Actualities and ambiguities 2002
- In-vivo angiogenesis and progestogens 2002
- Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system 1999
- Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel‐releasing intrauterine device or natural progesterone 1998
- Intrauterine administration of levonorgestrel 5 and 10 μg/24 hours in perimenopausal hormone replacement therapy 1997
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00